Prevención y manejo de la enfermedad tromboembólica venosa en el síndrome de Cushing. Una propuesta a partir de un caso y revisión de la literatura
DOI:
https://doi.org/10.17533/udea.iatreia.320Palabras clave:
Anticoagulantes, Embolia, Síndrome de Cushing, TrombosisResumen
Introducción: el síndrome de Cushing se asocia a múltiples complicaciones, dentro de las cuales la enfermedad tromboembólica es frecuente y genera una morbimortalidad significativa.
Objetivos: realizar una revisión de tema a partir de un caso clínico.
Metodología: en el presente artículo se presenta un caso clínico a partir del cual se hace una revisión de los aspectos epidemiológicos, fisiopatológicos y, al final, una propuesta de manejo de la enfermedad tromboembólica venosa a partir de la evidencia disponible en la literatura médica.
Conclusiones: el síndrome de Cushing se asocia a un riesgo alto de fenómenos tromboembólicos; se requiere un manejo adecuado con tromboprofilaxis y anticoagulación y medidas no farmacológicas para evitar las complicaciones en los afectados.
Descargas
Citas
(1) Gutiérrez-Restrepo J, Latorre-Sierra G, Campuzano-Maya G. Síndrome de Cushing. Med y Lab [Internet]. 2009;15(9-10):411-30. Disponible en: https://dialnet.unirioja.es/servlet/articulo?codigo=8741768
(2) Hatipoglu BA. Cushing's syndrome. J Surg Oncol [Internet]. 2012;106(5):565-71. https://doi.org/10.1002/jso.23197
(3) Lindholm J, Juul S, Jorgensen J, Astrup J, Bjerre P, Feldt-Rasmussen U, et al. Incidence and late prognosis of Cushing's syndrome: a population-based study. Endocrinol Metab [Internet]. 2001;86(1):117-23. https://doi.org/10.1210/jcem.86.1.7093
(4) Lau D, Rutledge C, Aghi M. Cushing's disease: current medical therapies and molecular insights guiding future therapies. Neurosurg Focus [Internet]. 2015;38(2):E11. https://doi.org/10.3171/2014.10.FOCUS14700
(5) Gutiérrez-Restrepo J, Gómez-Corrales J, Restrepo-Giraldo LM, Builes-Barrera C, Toro-Lugo C, Tobón-Escobar J, et al. Características clínicas y epidemiológicas del síndrome de Cushing. Medellín, 1986-2010. Med y Lab [Internet]. 2013;19(9-10):473-85. Disponible en: https://dialnet.unirioja.es/servlet/articulo?codigo=8741661
(6) Pivonello R, De Martino M, De Leo M, Lombardi G, Colao A. Cushing's Syndrome. Endocrinol Metab Clin North Am [Internet]. 2008;37(1):135-49. https://doi.org/10.1016/j.ecl.2007.10.010
(7) St-Jean M, Lim DST, Langlois F. Hypercoagulability in Cushing's syndrome: From arterial to venous disease. Best Pract Res Clin Endocrinol Metab [Internet]. 2021;35(2):101496.
https://doi.org/10.1016/j.beem.2021.101496
(8) Capatina C, Fleseriu M. Thromboembolic disease in hypercortisolism. Curr Opin Endocrinol Diabetes Obes [Internet]. 2021;28(3):330-6. https://doi.org/10.1097/MED.0000000000000630
(9) Van-Zaane B, Nur E, Squizzato A, Dekkers O, Twickler M, Fliers E, et al. Hypercoagulable state in Cushing's syndrome: a systematic review. J Clin Endocrinol Metab [Internet]. 2009;94(8):2743-50. https://doi.org/10.1210/jc.2009-0290
(10) Barahona MJ, Resmini E, Viladés D, Pons-Lladó G, Leta R, Puig T, et al. Coronary artery disease detected by multislice computed tomography in patients after long-term cure of cushing's syndrome. J Clin Endocrinol Metab [Internet]. 2013;98(3):1093-9. https://doi.org/10.1210/jc.2012-3547
(11) Manzini JL. Declaración De Helsinki: Principios Éticos Para La Investigación Médica Sobre Sujetos Humanos. Acta Bioeth [Internet]. 2000;6(2):321-34. https://doi.org/10.4067/S1726-569X2000000200010
(12) Stuijver DJF, Van-Zaane B, Feelders RA, Debeij J, Cannegieter SC, Hermus AR, et al. Incidence of venous thromboembolism in patients with Cushing's syndrome: A multicenter cohort study. J Clin Endocrinol Metab [Internet]. 2011;96(11):3525-32. https://doi.org/10.1210/jc.2011-1661
(13) Wagner J, Langlois F, Ting-Lim DS, McCartney S, Fleseriu M. Hypercoagulability and risk of venous thromboembolic events in endogenous Cushing's syndrome: A systematic meta-analysis. Front Endocrinol (Lausanne) [Internet]. 2018;9:1-14. https://doi.org/10.3389/fendo.2018.00805
(14) Coelho MCA, Santos CV, Neto LV, Gadelha MR. Adverse effects of glucocorticoids: Coagulopathy. Eur J Endocrinol [Internet]. 2015;173(4):M11-21. https://doi.org/10.1530/EJE-15-0198
(15) Lopez-Montoya V, Gutiérrez-Restrepo J, Torres-Grajales J, Aristizabal N, Pantoja D, Roman-González A, et al. Ectopic Cushing syndrome in Colombia. Arch Endocrinol Metab [Internet]. 2021;64(6):687-94. https://doi.org/10.20945/2359-3997000000271
(16) Zilio M, Mazzai L, Sartori MT, Barbot M, Ceccato F, Daidone V. A venous thromboembolism risk assessment model for patients with Cushing's syndrome. Endocrine [Internet]. 2016;52(2):322-32. https://doi.org/10.1007/s12020-015-0665-z
(17) Johannesdottir SA, Horváth-Puh́o E, Dekkers OM, Cannegieter SC, Jørgensen JOL, Ehrenstein V, et al. Use of glucocorticoids and risk of venous thromboembolism: A nationwide population-based case-control study. JAMA Intern Med [Internet]. 2013;173(9):743-52. https://doi.org/10.1001/jamainternmed.2013.122
(18) Gutiérrez-Restrepo J. Efectos adversos de la terapia con glucocorticoides. Iatreia [Internet]. 2021;34(2):137-50. https://doi.org/10.17533/udea.iatreia.96
(19) Isidori A, Minetti M, Sbardella E, Graziadio C, Grossman A. Mechanisms in endocrinology: The spectrum of haemostatic abnormalities in glucocorticoid excess and defect. Eur J Endocrinol [Internet]. 2015;173(3):R101-13. https://doi.org/10.1530/EJE-15-0308
(20) Aranda G, Fernandez-Ruiz R, Palomo M, Romo M, Mora M, Halperin I, et al. Translational evidence of prothrombotic and inflammatory endothelial damage in Cushing syndrome after remission. Clin Endocrinol [Internet]. 2018;88(3):415-24. https://doi.org/10.1111/cen.13521
(21) Arnaldi G, Mancini T, Tirabassi G, Trementino L, Boscaro M. Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications. J Endocrinol Invest [Internet]. 2012;35(4):434-48. https://doi.org/10.1007/BF03345431
(22) Suarez MG, Stack M, Hinojosa-Amaya JM, Mitchell MD, Varlamov EV, Yedinak CG, et al. Hypercoagulability in Cushing syndrome, prevalence of thrombotic events: A large, single-center, retrospective study. J Endocr Soc [Internet]. 2020;4(2):1-11. https://doi.org/10.1210/jendso/bvz033
(23) Fukuoka H, Takeuchi T, Matsumoto R, Bando H, Suda K, Nishizawa H, et al. D-dimer as a significant marker of deep vein thrombosis in patients with subclinical or overt Cushing's syndrome. Endocr J [Internet]. 2014;61(10):1003-10. https://doi.org/10.1507/endocrj.EJ14-0102
(24) Small M, Lowe G, Forbes C, Thomson J. Thromboembolic complications in Cushing's syndrome. Clin Endocrinol. 1983;19(4):503-11. https://doi.org/10.1111/j.1365-2265.1983.tb00025.x
(25) Van Der Pas R, Bruin C, Leebeek FWG, De Maat MPM, Rijken DC, Pereira AM, et al. The hypercoagulable state in Cushing's disease is associated with increased levels of procoagulant factors and impaired fibrinolysis, but is not reversible after short-term biochemical remission induced by medical therapy. J Clin Endocrinol Metab [Internet]. 2012;97(4):1303-10. https://doi.org/10.1210/jc.2011-2753
(26) Manetti L, Bogazzi F, Giovannetti C, Raffaelli V, Genovesi M, Pellegrini G, et al. Changes in coagulation indexes and occurrence of venous thromboembolism in patients with Cushing's syndrome: Results from a prospective study before and after surgery. Eur J Endocrinol [Internet]. 2010;163(5):783-91. https://doi.org/10.1530/EJE-10-0583
(27) Boscaro M, Sonino N, Scarda A, Barzon L, Fallo F, Sartori MT, et al. Anticoagulant Prophylaxis Markedly Reduces Thromboembolic Complications in Cushing's Syndrome. J Clin Endocrinol Metab [Internet]. 2002;87(8):3662-6. https://doi.org/10.1210/jcem.87.8.8703
(28) Barbot M, Daidone V, Zilio M, Albiger N, Mazzai L, Sartori M. Perioperative thromboprophylaxis in Cushing's disease: What we did and what we are doing? Pituitary [Internet]. 2015;18(4):487-93. https://doi.org/10.1007/s11102-014-0600-y
(29) Suarez MG, Stack M, Hinojosa-Amaya JM, Mitchell MD, Varlamov EV, Yedinak CG, et al. Hypercoagulability in Cushing Syn¬drome Prevalence of thrombotic events: a large, Single-Center, Retrospective Study. J Endocr Soc. 2019 Dec 15;4(2):bvz033. https://doi.org/10.1210/jendso/bvz033
(30) Lopes V, Marques O, De Sousa-Lages A. Preventive strategies for hypercoagulation in Cushing’s syndrome: when and how. Thromb J [Internet]. 2023;21:72. https://doi.org/10.1186/s12959-023-00515-1
(31) Van Der Pas R, Leebeek FWG, Hofland LJ, De Herder WW, Feelders RA. Hypercoagulability in Cushing's syndrome: Prevalence, pathogenesis and treatment. Clin Endocrinol (Oxf) [Internet]. 2013;78(4):481-8. https://doi.org/10.1111/cen.12094
(32) Babic B, De Roulet A, Volpe A, Nilubol N. Is VTE prophylaxis necessary on discharge for patients undergoing adrenalectomy for cushing syndrome? J Endocr Soc [Internet]. 2019;3(2):304-13. https://doi.org/10.1210/js.2018-00278
(33) Obuobie K, Davies JS, Ogunko A, Scanlon MF. Venous thrombo-embolism following inferior petrosal sinus sampling in Cushing's disease. J Endocrinol Invest [Internet]. 2000;23(8):542-4. https://doi.org/10.1007/BF03343772
(34) Koraćević G, Stojanović M, Petrović S, Simić D, Sakač D, Vlajković M, et al. Cushing's syndrome, a risk factor for venous thromboembolism is a candidate for guidelines. Acta Endocrinol [Internet]. 2020;16(2):123-8. https://doi.org/10.4183/aeb.2020.123
(35) Ortel TL, Neumann I, Ageno W, Beyth R, Clark NP, Cuker A, et al. American society of hematology 2020 guidelines for management of venous thromboembolism: Treatment of deep vein thrombosis and pulmonary embolism. Blood Adv [Internet]. 2020;4(19):4693-738. https://doi.org/10.1182/bloodadvances.2020001830
(36) Anderson DR, Morgano GP, Bennett C, Dentali F, Francis CW, Garcia DA, et al. American Society of Hematology 2019 guidelines for management of venous thromboembolism: Prevention of venous thromboembolism in surgical hospitalized patients. Blood Adv [Internet]. 2019;3(23):3898-944. https://doi.org/10.1182/bloodadvances.2019000975
(37) Konstantinides SV, Meyer G, Bueno H, Galié N, Gibbs JSR, Ageno W, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European respiratory society (ERS). Eur Heart J [Internet]. 2020;41(4):543-603. https://doi.org/10.10993/eirheartj/ehz405
(38) Fleseriu M, Auchus R, Bancus I, Ben-Sjlomo A, Bertherat J, Biermasz NR, et al. Consensus on diagnosis and management of Cushing's disease: a guideline update. Lancet Diabetes Endocrinol [Internet]. 2021;9(12):847-875. https://doi.org/10.1016/S2213-8587(21)00235-7
(39) Luger A, Broersen LHA, Biermasz NR, Biller BMK, Buchfelder M, Chanson P, et al. ESE Clinical Practice Guideline on functioning and non-functioning pituitary adenomas in pregnancy. Eur J Endocrinol [Internet]. 2021 Aug 23;185(3):G1-G33. https://doi.org/10.1530/EJE-21-0462
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2025 Iatreia
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
Los artículos publicados en la revista están disponibles para ser utilizados bajo la licencia Creative Commons, específicamente son de Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional.
Los trabajos enviados deben ser inéditos y suministrados exclusivamente a la Revista; se exige al autor que envía sus contribuciones presentar los formatos: presentación de artículo y responsabilidad de autoría completamente diligenciados.
